Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jan 15, 2025; 16(1): 99526
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.99526
Table 1 Comparison of weight loss effects, as well as blood pressure and blood glucose indicators among the patients (n = 78)
Time
Weight (kg)
BMI (kg/m2)
SBP (mmHg)
DBP (mmHg)
FBG (mmol/L)
PBG (mmol/L)
HbA1c (%)
Preoperative69.5 ± 6.824.3 ± 2.3150.9 ± 10.2110.2 ± 9.210.5 ± 2.717.8 ± 2.69.2 ± 0.9
3 months postoperative69.2 ± 6.124.1 ± 2.4141.4 ± 8.2a98.6 ± 8.1a10.1 ± 1.612.8 ± 2.1a8.1 ± 0.7a
6 months postoperative67.4 ± 7.2a,b23.1 ± 2.5a,b135.2 ± 9.4b86.4 ± 8.6b7.2 ± 1.1a,b9.8 ± 2.3b7.1 ± 0.6b
Table 2 Comparison of pancreatic islet function indicators among patients (n = 78)
Time
FCP (ng/mL)
PCP (ng/mL)
Fins (uIU/mL)
Pins (uIU/mL)
HOMA-IR
HOMA-β
Preoperative1.1 ± 0.32.9 ± 0.416.8 ± 2.727.7 ± 3.67.7 ± 1.835.5 ± 5.2
3 months postoperative1.1 ± 0.22.9 ± 0.516.9 ± 2.928.1 ± 2.77.9 ± 1.935.9 ± 4.9
6 months postoperative1.2 ± 0.23.6 ± 0.4a,b19.1 ± 2.3a,b36.4 ± 2.9a,b6.1 ± 0.8a,b39.2 ± 4.1a,b
Table 3 Comparison of lipid and purine metabolic indicators among the patients (n = 78)
Time
ALT (U/L)
AST (U/L)
TC (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)
HDL-C (mmol/L)
UA (µmol/L)
Preoperative37. 1 ± 4.125.8 ± 3.65.2 ± 0.83.4 ± 0.74.2 ± 0.90.9 ± 0.08410. 9 ± 35.1
3 months postoperative38. 2 ± 3.124.6 ± 2.95.3 ± 0.72.6 ± 0.4a2.7 ± 0.5a1.0 ± 0.09405. 2 ± 30.4
6 months postoperative38. 9 ± 3.725.4 ± 2.24.2 ± 0.3a,b2.5 ± 0.6a2.0 ± 0.3b1.0 ± 0.07345. 2 ± 28.2a,b